PsyBio Therapeutics Corp.
PSYBF · OTC
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Market Cap | $3 | $6 | $2 | $11 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $3 | $7 | $2 | $11 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$0 | -$1 | -$1 | -$1 |
| % Margin | – | – | – | – |
| Net Income | -$0 | -$1 | -$1 | -$1 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.001 | -0.01 | -0.015 | -0.008 |
| % Growth | 86% | 33.3% | -80.7% | – |
| Operating Cash Flow | $0 | -$0 | -$0 | -$1 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $0 | -$0 | -$0 | -$1 |